[1]
|
Ogunbiyi, J.O. and Shittu, O.B. (1999) Increased Incidence of Prostate Cancer in Nigerians. Journal of the National Medical Association, 91, 159-64.
|
[2]
|
Agnihotri, S., Mittal, R.D., Kapoor, R. and Mandhani, A. (2014) Raising the Cut-Off Value of Prostate Specific Antigen (PSA) for Biopsy in Asymptomatic Men in India to Reduce Unnecessary Biopsy. Indian J Med Res, 139, 851-856.
|
[3]
|
Shah, S.J., Goyal, V., Sachar, R., Nath, A. and Bajaniya, S. (2009) Early Detection of Prostate Cancer in Patients with PSA Levels of 2.5 to 4.0 Ng/ml. GMJ, 64, 10-12.
|
[4]
|
Hunter, C. and Zamiara, P. (2012) The Role of Prostate-Specific Antigen (PSA) Testing in Screening for Prostate Cancer. UWOMJ, 18, 17-18.
|
[5]
|
National Cancer Institute. Prostate-Specific Antigen Test.
http://www.cancer.gov/cancertopics/factsheet/detection/PSA
|
[6]
|
Abrahamsson, P., Crwaford, E.D., Lucia, M.S., Sakr, W. and Schalken, J. (2003) Prostate Cancer: Epidemiology and screening. Reviews in Urology, 5, S3-S9.
|
[7]
|
Draisma, G., Etzioni, R., Tsodikov, A., Mariotto, A., Wever, E., Gulati, R., et al. (2009) Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context. Journal of the National Cancer Institute, 101, 374-383. https://doi.org/10.1093/jnci/djp001
|
[8]
|
Qureshi, Z.P., Bennett, C., Hermanson, T., Horner, R., Haider, R., Lee, M., et al. (2015) The Ethical Dilemma Surrounding Prostate Specific Antigen (PSA) Screening. Journal of Clinical Research and Bioethics, 6, 1.
|
[9]
|
Erhabor, O., Zama, I., Mainasara, A.S., Shehu, R.A., Iwueke, I.P., Aghedo, F., et al. (2014) Prostate Specific Antigen (PSA) Screening among Apparently Healthy Men of African Decent in Sokoto, North Western Nigeria. International Blood Research & Reviews, 2, 37-47. https://doi.org/10.9734/IBRR/2014/6362
|
[10]
|
Ukoli, F., Osime, U., Akereyeni, F., Okunzuwa, O., Kittles, R. and Adams-Campbell, L. (2003) Prevalence of Elevated Prostate Specific Antigen in Rural Nigeria. International Journal of Urology, 10, 315-322.
https://doi.org/10.1046/j.1442-2042.2003.00633.x
|
[11]
|
Akinremi, T.O., Adeniyi, A., Olutunde, A., Oduniyi, A. and Ogo, C.N. (2014) Need for and Relevance of Prostate Cancer Screening in Nigeria. Ecancer, 8, 457.
|
[12]
|
Lan, S., Tsai, Y., Lin, Y. and Tzai, T. (2007) Diagnostic Performance of a Random versus Lesion-Directed Biopsy of the Prostate from Transrectal Ultrasound. Journal of Ultrasound in Medicine, 26, 11-17. https://doi.org/10.7863/jum.2007.26.1.11
|
[13]
|
Luboldt, H., Schindler, J.F. and Rubben, H. (2007) Age Specific Reference Ranges for Prostate-Specific antigen as a Marker for Prostate Cancer. EAU-EBU Update Series, 5, 38-48.
|
[14]
|
Adeloye, D., David, R.A., Aderemi, A.V., Iseolorunkanmi, A., Oyedokun, A., Iweala, E.E.J., et al. (2016) An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis. PLoS ONE, 11, e0153496.
https://doi.org/10.1371/journal.pone.0153496
|
[15]
|
Mejak, S.L., Bayliss, J. and Hanks, S.D. (2013) Long Distance Bicycle Riding Causes Prostate-Specific Antigen to Increase in Men Aged 50 Years and Over. PLoS ONE, 8, e56030. https://doi.org/10.1371/journal.pone.0056030
|
[16]
|
Kim, S., Jang, K., Park, W., Kwon, D., Kang, W. and Lim, H. (2014) Serum Prostate-Specific Antigen Levels and Type of Work in Tire Manufacturing Workers. Annals of Occupational and Environmental Medicine, 26, 50.
https://doi.org/10.1186/s40557-014-0050-z
|
[17]
|
Madersbacher, S., Alcaraz, A., Emberton, M., Hammerer, P., Ponholzer, A. and Schroder, F.H. (2011) The Influence of Family History on Prostate Cancer Risk: Implications for Clinical Management. BJU International, 107, 716-721.
https://doi.org/10.1111/j.1464-410X.2010.10024.x
|
[18]
|
Bratt, O., Drenn, L., Akre, O., Garmo, H. and Stattin, P. (2016) Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population Based Study. Journal of the National Cancer Institute, 108, djw110.
https://doi.org/10.1093/jnci/djw110
|
[19]
|
Cancer Genetics Editorial Board. PDQ Genetics of Prostate Cancer. National Cancer Institute, Bethesda, MD. http://www.cancer.gov/types
|
[20]
|
Silberstein, J.W., Downs, T., Lakin, C. and Kune, C.J. (2009) HIV and Prostate Cancer: A Systematic Review of the Literature. Prostate Cancer and Prostatic Diseases, 12, 6-12. https://doi.org/10.1038/pcan.2008.44
|
[21]
|
Marcus, J.L., Chao, C.R., Leyden, W.A., Xu, L., Klein, D.B., Horberg, M.A., et al. (2004) Prostate Cancer Incidence and Prostate Specific Antigen Testing among HIV Positive and HIV Negative Men. Journal of Acquired Immune Deficiency Syndromes, 66, 495-502. https://doi.org/10.1097/QAI.0000000000000202
|
[22]
|
Shiels, M.S., Goedert, J.J., Moore, R.D., Platz, E.A. and Engels, E.A. (2010) Reduced Risk of Prostate Cancer in US Men with AIDS. Cancer Epidemiology, Biomarkers & Prevention, 19, 2910-2915. https://doi.org/10.1158/1055-9965.EPI-10-0741
|